Subsidiaries


Beijing Fert Technology Co., Ltd.

  Beijing Fert Technology Co., Ltd. was founded in 1997 and is one of the earliest enterprises in China to develop and manufacture precision filter infusion sets. It is also one of the first companies to adopt nuclear track membrane technology and hold proprietary intellectual property rights for precision filtration, and has participated in the formulation of multiple national and industry standards for precision filter infusion set products. Fert is also one of the first three domestic manufacturers to produce and promote non-PVC-based medical products, opening a new chapter for safe infusion in China. As a leading enterprise in the infusion care field, Fert has further extended its product portfolio to intravenous cannula products and diabetes and dialysis care-related products, actively conducting research, development, and industrial deployment in other care-related fields, and continuously contributing to the safety and efficiency of medical care.

 

For more information about Fert, please visit https://www.china-fert.com

 

 

Chengdu OCI Medical Devices Co., Ltd.

  Chengdu OCI Medical Devices Co., Ltd. was founded in 2005 and is a wholly-owned subsidiary of Sichuan Ruijian Medical Technology Co., Ltd. Its principal business is the R&D, manufacturing, and sales of blood purification medical device products. The company holds multiple proprietary intellectual property rights and has independently developed, designed, and manufactured a full-process production line for hemodialyzers, spanning from front-end membrane spinning to back-end assembly. Its high-flux hemodialyzer was the first domestically developed product in China to obtain registration approval, and its hemodiafilter was among the first domestic products approved through the priority review channel. The company’s products rank among the leaders in China by market share and are also exported to multiple overseas markets. As a pioneer in the domestic blood dialysis consumables sector, the company will continue to develop and improve the materials and performance of its blood purification products and to expand its existing product portfolio.

 

For more information about OCI Medical, please visit http://www.cdoci.com.cn

 


 

Beijing Ruijian High-Tech Biological Technology Co., Ltd


     Beijing Ruijian High-Tech Biological Technology Co., Ltd. was founded in 2013 and is an innovative biotechnology company. It adopts the latest generation of tissue regenerative material technology for the R&D and manufacturing of animal-derived regenerative medical biomaterials and human tissue repair alternative products.Ruijian Biological has strong R&D capabilities. Dr. Sun Wenquan, its general manager and chief scientist, has over 30 years of experience in tissue repair and regenerative medical biomaterials research. The company has a robust product pipeline, including biological patches, biological dressings, oral biological membranes, breast tissue patches, injectable particles, and biological sponges, with applications broadly covering both medical and medical aesthetics fields.